Alpha Mannosidosis Global Market Report 2022 – By Therapy Type (Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy), By Indication (Type I, Type II, Type III), By End-User ( Hospitals, Speciality Clinics)– Market Size, Trends, And Global Forecast 2022-2026

Starting Price : $5000.00 | Pages : 150 | Published : February 2022 | SKU CODE : | Delivery Time: 2-3 business days | Format :


The alpha mannosidosis market consists of sales of therapies for alpha mannosidosis (organizations, sole traders and partnerships) that provides treatment for alpha mannosidosis, which is a lysosomal storage disorder. Lysosomes are particles bound in membranes within cells that function as the primary digestive units. Alpha-mannosidosis is a rare genetic inherited condition that affects the organs and tissues of the person suffering from the disease. The treatment therapy focuses on detecting and preventing polysaccharide accumulations within mutant cells, which can cause harm to tissue, organs, and eventually death. Polysaccharides are defined as larger molecules composed of several linked sugar molecules.

The main types of therapy for alpha mannosidosis are bone marrow transplant (BMT), enzyme replacement therapy (ERT), peripheral blood stem cell transplantation (PBSCT) and gene therapy. A bone marrow transplant is a procedure in which dysfunctional marrow is replaced with healthy marrow. The different types of indications include Type I, Type II and Type III and is implemented in wide range of verticals such as hospitals and specialty clinics.

The global alpha mannosidosis market size is expected to grow from $8.89 million in 2021 to $10.56 million in 2022 at a compound annual growth rate (CAGR) of 18.8%. The growth in the market is mainly due to increasing prevalence of alpha mannosidosis, use of orphan drugs, fee reductions and tax credits, increasing investment in the rare disease treatment and advancements in treatment drugs. The alpha mannosidosis market is expected to reach $20.61 million in 2026 at a CAGR of 18.2%.

The increasing investments on research is expected to contribute to the growth of the alpha mannosidosis market in the forecast period. Currently, in the alpha mannosidosis market, only one company has therapies for the rare genetic disease. However, several firms have products in the clinical stages, which will boost market demand in the forecast period. For instance, in 2020, the EU clinical trials database lists 39,219 clinical trials with a EudraCT protocol, 6,426 of which are clinical trials involving subjects under the age of 18. Therefore, the increasing investments on research fuels the growth of the alpha mannosidosis market.

The advancements in treatment for alpha mannosidosis like pharmacological therapy are gaining traction in the alpha mannosidosis market. For instance, Chiesi Group, an international research-focused Healthcare company, announced that it has received a positive opinion recommending the marketing authorization of Velmanase Alfa, under the brand name Lamzede from the European Medicines Agency Committee for Medicinal Products for Human Use. Lamzede is an enzyme replacement therapy intended to provide or supplement natural alpha-mannosidase, an enzyme that helps with the degradation of mannose–rich oligosaccharides and thus prevents their accumulation in various tissues in the body.

Major players in the market are Chiesi Farmaceutici S.p.A., Nuo Therapeutics, and Zymenex.

North America was the largest region in the alpha mannosidosis market in 2021. Asia Pacific is expected to be the fastest growing region in the forecast period. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the alpha mannosidosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

The global alpha mannosidosis market is segmented -

1) By Therapy Type: Bone Marrow Transplant (BMT), Enzyme Replacement Therapy (ERT), Peripheral Blood Stem Cell Transplantation (PBSCT), Gene Therapy

2) By Indication: Type I, Type II, Type III

3) By End-User: Hospitals, Speciality Clinics

    Table Of Contents

    1. Executive Summary

    2. Alpha Mannosidosis Market Characteristics

    3. Alpha Mannosidosis Market Trends And Strategies

    4. Impact Of COVID-19 On Alpha Mannosidosis

    5. Alpha Mannosidosis Market Size And Growth

    5.1. Global Alpha Mannosidosis Historic Market, 2016-2021, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Alpha Mannosidosis Forecast Market, 2021-2026F, 2031F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Alpha Mannosidosis Market Segmentation

    6.1. Global Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Bone Marrow Transplant (BMT)

    Enzyme Replacement Therapy (ERT)

    Peripheral Blood Stem Cell Transplantation (PBSCT)

    Gene Therapy

    6.2. Global Alpha Mannosidosis Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Type I

    Type II

    Type III

    6.3. Global Alpha Mannosidosis Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    Hospitals

    Speciality Clinics

    7. Alpha Mannosidosis Market Regional And Country Analysis

    7.1. Global Alpha Mannosidosis Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    7.2. Global Alpha Mannosidosis Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    8. Asia-Pacific Alpha Mannosidosis Market  

    8.1. Asia-Pacific Alpha Mannosidosis Market Overview  

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    9. China Alpha Mannosidosis Market  

    9.1. China Alpha Mannosidosis Market Overview  

    9.2. China Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

    10. India Alpha Mannosidosis Market  

    10.1. India Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    11. Japan Alpha Mannosidosis Market  

    11.1. Japan Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    12. Australia Alpha Mannosidosis Market  

    12.1. Australia Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    13. Indonesia Alpha Mannosidosis Market  

    13.1. Indonesia Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    14. South Korea Alpha Mannosidosis Market  

    14.1. South Korea Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    15. Western Europe Alpha Mannosidosis Market  

    15.1. Western Europe Alpha Mannosidosis Market Overview

    15.2. Western Europe Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    16. UK Alpha Mannosidosis Market  

    16.1. UK Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    17. Germany Alpha Mannosidosis Market  

    17.1. Germany Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    18. France Alpha Mannosidosis Market  

    18.3. France Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    19. Eastern Europe Alpha Mannosidosis Market  

    19.1. Eastern Europe Alpha Mannosidosis Market Overview

    19.2. Eastern Europe Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    20. Russia Alpha Mannosidosis Market  

    20.1. Russia Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    21. North America Alpha Mannosidosis Market  

    21.1. North America Alpha Mannosidosis Market Overview

    21.2. North America Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    22. USA Alpha Mannosidosis Market  

    22.1. USA Alpha Mannosidosis Market Overview

    22.2. USA Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    23. South America Alpha Mannosidosis Market  

    23.1. South America Alpha Mannosidosis Market Overview

    23.2. South America Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    24. Brazil Alpha Mannosidosis Market  

    24.1. Brazil Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    25. Middle East Alpha Mannosidosis Market  

    25.1. Middle East Alpha Mannosidosis Market Overview

    25.2. Middle East Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    26. Africa Alpha Mannosidosis Market  

    26.1. Africa Alpha Mannosidosis Market Overview

    26.2. Africa Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

    27. Alpha Mannosidosis Market Competitive Landscape And Company Profiles

    27.1. Alpha Mannosidosis Market Competitive Landscape

    27.2. Alpha Mannosidosis Market Company Profiles

    27.2.1. CHIESI Farmaceutici SpA

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Nuo Therapeutics

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Zymenex

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    28. Key Mergers And Acquisitions In The Alpha Mannosidosis Market

    29. Alpha Mannosidosis Market Future Outlook and Potential Analysis

    30. Appendix

    30.1. Abbreviations

    30.2. Currencies

    30.3. Research Inquiries

    30.4. The Business Research Company

    30.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Table 3: Global Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 4: Global Alpha Mannosidosis Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 5: Global Alpha Mannosidosis Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 6: Global Alpha Mannosidosis Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 7: Global Alpha Mannosidosis Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 8: Asia-Pacific, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 9: China, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 10: India, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 11: Japan, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 12: Australia, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 13: Indonesia, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 14: South Korea, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 15: Western Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 16: UK, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 17: Germany, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 18: France, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 19: Eastern Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 20: Russia, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 21: North America, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 22: USA, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 23: South America, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 24: Brazil, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 25: Middle East, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 26: Africa, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Table 27: CHIESI Farmaceutici SpA Financial Performance
  • Table 28: Nuo Therapeutics Financial Performance
  • Table 29: Zymenex Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
  • Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
  • Figure 3: Global Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 4: Global Alpha Mannosidosis Market, Segmentation By Indication, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 5: Global Alpha Mannosidosis Market, Segmentation By End-User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 6: Global Alpha Mannosidosis Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 7: Global Alpha Mannosidosis Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 8: Asia-Pacific, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 9: China, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 10: India, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 11: Japan, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 12: Australia, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 13: Indonesia, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 14: South Korea, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 15: Western Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 16: UK, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 17: Germany, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 18: France, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 19: Eastern Europe, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 20: Russia, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 21: North America, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 22: USA, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 23: South America, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 24: Brazil, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 25: Middle East, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 26: Africa, Alpha Mannosidosis Market, Segmentation By Therapy Type , Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Figure 27: CHIESI Farmaceutici SpA Financial Performance
  • Figure 28: Nuo Therapeutics Financial Performance
  • Figure 29: Zymenex Financial Performance
Global Contract Research And Manufacturing Services (CRAMS) Market Size, Forecasts, And Opportunities – Includes CRAMS Market Overview
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Molecular Diagnostics Devices And Equipment Global Market Report 2022 – By Product (Instruments, Reagents, Consumables), By End User (Diagnostic laboratories, Hospitals, Others( nursing home, blood banks, point of care)), By Technology (DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Others (southern blotting, northern blotting, electrophoresis)), By Application (Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Neurological disease, Cardiovascular disease) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Gene Therapy Global Market Report 2022 – By Gene Type (Antigen, Cytokine, Suicide Gene), By Vector (Viral Vector, Non-Viral Vector), By Application (Oncological Disorders, Rare Diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases), By End Users (Hospitals, Homecare, Specialty Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report
CRISPR Technology Global Market Report 2022 – By Product Type (Design Tools, Plasmid And Vector, Cas9 And G-RNA, Delivery System Products), By Application (Genome Editing/ Genetic Engineering, Genetically Modified Organisms, Agricultural Biotechnology), By End Use (Industrial Biotech, Biological Research, Agricultural Research, Therapeutics And Drug Discovery) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Gene Editing Global Market Report 2022 – By Technology (CRISPR, TALEN, ZFN), By End Users (Biotechnology, Pharmaceutical, Contract Research Organization), By Application (Animal Genetic Engineering, Plant Genetic Engineering, Cell Line Engineering) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Stem Cell/Cord Blood Banking Global Market Report 2022 – By Cell Type (Adult Stem Cells, Umbilical Cord Blood Stem Cells, Embryonic Stem Cells), By Service (Collection, Processing, Analysis, Storage), By Bank Type (Public, Private), By Application (Leukaemia, Anaemia, Thalassemia, Autism, Cerebral Palsy, Diabetes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Genomics Global Market Report 2022 – By Product Type (Instrument (Including Systems, Service Contract And Software), Reagents (Including Reagents And Consumables)), By Process (Cell Isolation, Sample Preparation, Genomic Analysis), By End User (Academic Institutes, Biopharmaceutical Companies, Clinical Research Institutes) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Stem Cell Global Market Report 2022 – By Source (Autologous, Allogeneic), By Product Type (Adult Stem Cell, Human Embryonic Stem Cell, Induced Pluripotent Stem Cell, Others), By Application (Regenerative Medicine, Drug Discovery And Development) – Market Size, Trends, And Global Forecast 2022-2026
View Report
Stem Cell Therapy Global Market Report 2022 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders), By End-User (Hospitals, Clinics) – Market Size, Trends, And Global Forecast 2022-2026
View Report